Evidence map›Paper›PMID 32905515›Full record

ArticleAmerican journal of cancer research2020

Combination of carbon-ion beam and dual tyrosine kinase inhibitor, lapatinib, effectively destroys HER2 positive breast cancer stem-like cells.

Sei Sai, Eun Ho Kim, Guillaume Vares, Masao Suzuki, Dong Yu, Yoshiya Horimoto, Mitsuhiro Hayashi

Open access · greenAbstract read
In one paragraph

Article in American journal of cancer research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Value of Carbon-Ion Radiation Therapy for Breast Cancer.International journal of particle therapy · 2024
    Review
  3. Article
  4. Review
  5. Basic and translational research on carbon-ion radiobiology.American journal of cancer research · 2023
    Review
  6. Review
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Sei SaiDepartment of Basic Medical Sciences for Radiation Damages, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology Chiba, Japan.
Eun Ho KimDepartment of Biochemistry, School of Medicine, Daegu Catholic University Nam-gu, Daegu 42472, South Korea.
Guillaume VaresOkinawa Institute of Science and Technology (OIST), Advanced Medical Instrumentation Unit Tancha 1919-1, Onna-son, Okinawa 904-0495, Japan.
Masao SuzukiDepartment of Basic Medical Sciences for Radiation Damages, National Institute of Radiological Sciences, National Institutes for Quantum and Radiological Science and Technology Chiba, Japan.
Dong YuSchool of Radiological Medicine and Protection, Medical College of Soochow University Suzhou 215006, China.
Yoshiya HorimotoDepartment of Breast Oncology, Juntendo University School of Medicine 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
Mitsuhiro HayashiBreast Center, Dokkyo Medical University Hospital 880 Kita-Kobayashi, Mibu-machi, Shimotsuga-gun, Tochigi 321-0293, Japan.
National Institutes for Quantum and Radiological Science and Technology · JPCatholic University of Daegu · KRJuntendo University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To investigate whether carbon-ion beam alone, or in combination with lapatinib, has a beneficial effect in targeting HER2-positive breast cancer stem-like cells (CSCs) compared to that of X-rays, human breast CSCs derived from BT474 and SKBR3 cell lines were treated with a carbon-ion beam or X-rays irradiation alone or in combination with lapatinib, and then cell viability, spheroid formation assays, apoptotic analyses, gene expression analysis of related genes, and

Indexed as

breast cancer stem cellHeavy-ion radiationlapatinib

Identifiers

PMID32905515
PMCPMC7471364
OpenAlexW3086164487

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.